Professor Gary Hull, director of the Program on Values and Ethics in the Marketplace of Duke University, will present a moral defense of the pharmaceutical industry's unconditional right to patents. Hull argues that this right is being violated by price caps, state-imposed limits on pharmaceutical advertising, and educational programs, compulsory licensing, special favors for generics, and limits on ancillary patents. Sponsored by Duke Law IPCS. For more information, contact Elizabeth Laughton at email@example.com.
The Moral Right to Pharmaceutical Patents
- Teachout ’99 discusses “Corruption in America” in advance of her March 24 visit to Duke Law
- Arata '13 examines "Ag Gag in NC" North Carolina Bar Association (password required)
- Helfer discusses designing legal institutions with incentives for states to join and cooperate Kenan Institute: Good Question